What is pneumonitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Pneumonitis is defined as focal or diffuse inflammation of the lung parenchyma, typically identified on computed tomography imaging, and can be caused by various factors including immune checkpoint inhibitor therapy, environmental irritants, medication side effects, and autoimmune conditions. The symptoms of pneumonitis may include new or worsening cough, shortness of breath, increased oxygen requirement, chest pain, and/or fever, as reported in a study published in the Journal of Clinical Oncology 1.

Causes and Risk Factors

The causes of pneumonitis can be diverse, ranging from exposure to environmental irritants like mold, bird proteins, or chemicals, to medication side effects from drugs such as chemotherapy agents or antibiotics, and radiation therapy to the chest, as well as autoimmune conditions. A study published in the Journal for ImmunoTherapy of Cancer found that the incidence of pneumonitis in patients treated with immune checkpoint inhibitors can vary, with an overall incidence of 2.7% reported in a meta-analysis of 20 studies with PD-1 inhibition 1.

Diagnosis and Treatment

Diagnosis of pneumonitis often involves computed tomography imaging, and treatment depends on the underlying cause but may include removing the triggering substance, corticosteroids like prednisone, oxygen therapy for severe cases, and sometimes immunosuppressants for autoimmune-related pneumonitis. According to a study published in the Journal of Clinical Oncology, the treatment of patients with symptomatic ICPi pneumonitis with corticosteroids is recommended as an initial treatment, based on several studies that report clinical improvement in > 80% of cases 1.

Management of Immune-Related Adverse Events

For patients with grades 1–2 pneumonitis, management may include drug withdrawal, and for those with pneumonitis grade 3 or higher, hospitalization is typically required, as detailed in a study published in the Journal for ImmunoTherapy of Cancer 1. The study also recommends a minimum 4–6 week taper of corticosteroids to prevent recrudescence of pneumonitis signs and symptoms.

Key Considerations

It is essential to note that pneumonitis can progress to permanent lung scarring (pulmonary fibrosis) if left untreated, emphasizing the importance of prompt medical attention when experiencing respiratory symptoms. The condition differs from pneumonia, which is specifically caused by infection rather than irritation or inflammation from non-infectious sources. A study published in the Journal of Clinical Oncology highlights the importance of being aware of the possibility of immune-related pulmonary reactions, which can mimic disease progression on imaging and examination 1.

From the Research

Definition of Pneumonitis

Pneumonitis refers to inflammation of the lungs, which can be caused by various factors such as infection, exposure to certain chemicals or pollutants, or as a result of an allergic reaction.

Types of Pneumonitis

  • Infectious pneumonitis: caused by bacteria, viruses, or fungi
  • Chemical pneumonitis: caused by inhalation of toxic substances
  • Hypersensitivity pneumonitis: an allergic reaction to certain substances

Community-Acquired Pneumonia

Community-acquired pneumonia (CAP) is a type of pneumonitis that occurs outside of a hospital setting, and can be caused by a variety of bacteria, viruses, and other microorganisms 2, 3, 4.

Treatment of Community-Acquired Pneumonia

The treatment of CAP typically involves the use of antibiotics, such as azithromycin, ceftriaxone, and amoxicillin-clavulanate 5, 2, 3, 4, 6. The choice of antibiotic depends on the severity of the infection, the patient's age and health status, and the suspected cause of the infection.

Antibiotics Used to Treat Pneumonitis

  • Azithromycin: a macrolide antibiotic effective against a wide range of bacteria, including those that cause CAP 5, 2, 3, 4
  • Ceftriaxone: a third-generation cephalosporin antibiotic effective against a wide range of bacteria, including those that cause CAP 2, 6
  • Amoxicillin-clavulanate: a combination antibiotic effective against a wide range of bacteria, including those that cause CAP 4

Related Questions

What is the management in the Emergency Department (ED) for a patient with bilateral pneumonia, hepatosplenomegaly (enlargement of the liver and spleen) with hepatic steatosis (fatty liver disease), leukocytosis (elevated White Blood Cell (WBC) count), and elevated liver enzymes (hypertransaminasemia)?
What treatment options or antibiotics are indicated for a 43-year-old female with atrial fibrillation (a fib) taking Eliquis (apixaban) and metoprolol, presenting with a 2-week cough and concern for pneumonia?
What are the clinical manifestations of a patient with pneumonia?
What antibiotic can be added to Augmentin (amoxicillin-clavulanate) for mild pneumonia in a patient who cannot take Azithromycin?
What is the recommended duration of antibiotic treatment for community-acquired pneumonia treated with azithromycin and ceftriaxone (Ceftriaxone) and oral Augmentin (Amoxicillin-Clavulanate)?
What are the treatment options for gonorrhea in patients with a cephalosporin (antibiotic) allergy?
Which benzimidazole (anti-parasitic medication) has the least effect on the QTc (corrected QT) interval?
What is the primary component of burn shock, in terms of hypovolemic, distributive, or cardiogenic shock, and how does it develop over time?
Which benzodiazoles (antifungal medications) are effective against Candida (fungal infection)?
What is the diagnosis and treatment for atypical pneumonia?
What is the diagnosis for a patient with diminished arterial pulses, warm to cold skin temperature gradient from proximal to distal, moderate non-pitting edema on the medial border of the left hallux toenail, erythema, and sparse hair growth, with normal venous flow and no varicosities?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.